Maze Therapeutics at Guggenheim conference: enrollment beats guide

🌐 Investing.com (Cyprus) —
Maze Therapeutics at Guggenheim conference: enrollment beats guide

AI Summary

Maze Therapeutics said enrollment in a clinical program exceeded its guidance during a Guggenheim conference. The headline does not identify the trial or provide additional enrollment figures.

Markets Health Maze Therapeutics clinical trial enrollment biotechnology Guggenheim conference

Read original source →